Japanese specialty pharmaceutical company, “EA Pharma Co., Ltd.” is currently seeking drug/target candidates for Pancreatic diseases.
EA Pharma Co., Ltd. is a gastrointestinal specialty pharma, established in April 2016 through the integration of the respective gastrointestinal business units of the Eisai Group and the Ajinomoto Group.
EA Pharma Co., Ltd. aims to be a human health care (hhc) company that can get close to patients su ering from gastrointestinal diseases through specialized research and development as well as a unique product lineup, and provide a wide range of solutions to patients and their families.
Check the pdf file to know more about this opportunity.
Download the RFP
Comments are closed.